Evidence map›Paper›PMID 18055812›Full record

ArticleInvestigative ophthalmology & visual science2007

Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice.

Douglas A Jabs, Robert A Prendergast, Adam L Campbell, Bella Lee, Esen Karamursel Akpek, Hervé C Gérard, Alan P Hudson, Judith A Whittum-Hudson

Abstract readComparative Study
In one paragraph

Article in Investigative ophthalmology & visual science, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Mouse Models of Sjögren's Syndrome with Ocular Surface Disease.International journal of molecular sciences · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Sjögren's syndrome: an old tale with a new twist.Archivum immunologiae et therapiae experimentalis
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Douglas A JabsDepartment of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. douglas.jabs@mssm.edu
Robert A Prendergast
Adam L Campbell
Bella Lee
Esen Karamursel Akpek
Hervé C Gérard
Alan P Hudson
Judith A Whittum-Hudson
Bipar · FRJohns Hopkins University · US

Funding

REITERS SYNDROME--MECHANISM OF CHLAMYDIA PATHOGENESISR01AR042541 · NIAMS · WAYNE STATE UNIVERSITY · PI HUDSON, ALAN PAUL · 1993 to 2008
$2.6M
Pathogenic mechanisms in chlamydial reactive arthritisR01AR048331 · NIAMS · WAYNE STATE UNIVERSITY · PI WHITTUM-HUDSON, JUDITH A · 2001 to 2005
$1.5M
ANTICHLAMYDIAL PROTECTION BY MOLECULAR MIMCRYR01AI044493 · NIAID · WAYNE STATE UNIVERSITY · PI WHITTUM-HUDSON, JUDITH A · 1998 to 2002
$781k
OCULAR IMMUNOPATHOLOGY IN AUTOIMMUNE MODELSR01EY005912 · NEI · JOHNS HOPKINS UNIVERSITY · PI JABS, DOUGLAS A · 1986 to 2001
$763k
NEI NIH HHS R01 EY005912NIAID NIH HHS R01 AI044493NIAMS NIH HHS R01 AR042541NIAMS NIH HHS R01 AR048331
6 · The paper itself

Abstract

purposeMRL/MpJ mice of substrains MRL/MpJ-fas(+)/fas(+) (MRL/+) and MRL/MpJ-fas(lpr)/fas(lpr) (MRL/lpr) spontaneously develop autoimmune dacryoadenitis and sialadenitis and are a model for the human disorder Sjögren syndrome. The dacryoadenitis in both substrains appears to be Th2 in nature, with little IFN-gamma and substantial IL-4 at the site of lacrimal gland inflammation.

methodsMRL/MpJ mice with a defective IL-4 gene-both MRL/+-IL-4(tm)/IL-4(tm) (MRL/+/IL-4(tm)) and MRL/lpr-IL-4(tm)/IL-4(tm) (MRL/lpr-IL-4(tm))-that resulted in a loss of IL-4 production were bred and evaluated for dacryoadenitis.

resultsMRL/+/IL-4(tm) and MRL/lpr/IL-4(tm) mice developed dacryoadenitis of similar onset, appearance, and severity as found in MRL/MpJ mice with an intact IL-4 gene. Immunohistochemistry examination revealed a substantially greater number of inflammatory cells staining for IFN-gamma than for IL-13 in the dacryoadenitis of IL-4-deficient MRL/MpJ mice (MRL/+/IL-4(tm), 66% vs. 0.8%, P = 0.001; MRL/lpr/IL-4(tm), 67% vs. 1.2%, P = 0.002). Real-time PCR demonstrated greater amounts of IFN-gamma than IL-13 mRNA relative transcripts in lacrimal glands of MRL/lpr/IL-4(tm) mice (mean difference, 28.6; P = 0.035). Greater CD86 (B7-2) than CD80 (B7-1) expression was present in MRL/+/IL-4(tm) mice (11% vs. 3%, P = 0.003) and MRL/lpr/IL-4(tm) mice (10% vs. 3%, P = 0.002).

conclusionsThese results suggest that a Th2 autoimmune process can be converted to a Th1 process in the absence of IL-4.

Indexed as

AnimalsAutoimmune DiseasesB7-1 AntigenB7-2 AntigenDacryocystitisFemaleGene SilencingImmunoenzyme TechniquesInterferon-gammaInterleukin-13Interleukin-4MaleMiceMice, Inbred BALB CMice, Inbred MRL lprMice, KnockoutB7-1 AntigenB7-2 AntigenInterferon-gammaInterleukin-13Interleukin-4RNA, Messenger

Identifiers

PMID18055812
PMCPMC2215323
OpenAlexW2012344956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.